Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.59 Billion INR | 391.94% |
| 2022 | 324.81 Million INR | -7.15% |
| 2021 | 349.84 Million INR | -84.91% |
| 2020 | 2.31 Billion INR | -0.18% |
| 2019 | 2.32 Billion INR | 37.15% |
| 2018 | 1.69 Billion INR | -24.23% |
| 2017 | 2.23 Billion INR | 507.42% |
| 2016 | 367.87 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.68 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.09 Billion INR | 0.0% |
| 2023 FY | 1.59 Billion INR | 391.94% |
| 2023 Q4 | 1.59 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 324.81 Million INR | -7.15% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 324.81 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 626.28 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 349.84 Million INR | -84.91% |
| 2021 Q4 | 349.84 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 490.58 Million INR | 0.0% |
| 2020 Q4 | 2.31 Billion INR | 0.0% |
| 2020 FY | 2.31 Billion INR | -0.18% |
| 2019 Q4 | 7.26 Billion INR | 0.0% |
| 2019 FY | 2.32 Billion INR | 37.15% |
| 2018 FY | 1.69 Billion INR | -24.23% |
| 2017 FY | 2.23 Billion INR | 507.42% |
| 2016 FY | 367.87 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 2.46 Billion INR | 35.282% |
| Metropolis Healthcare Limited | 1.97 Billion INR | 18.916% |
| Thyrocare Technologies Limited | 423.4 Million INR | -277.393% |
| Vijaya Diagnostic Centre Limited | 2.59 Billion INR | 38.349% |
| Vimta Labs Limited | 191.89 Million INR | -732.706% |